Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2265261 Title: SYSTÈMES D'ADMINISTRATION DE MÉDICAMENTS COMPRENANT DES MÉDICAMENTS FAIBLEMENT BASIQUES ET DES ACIDES ORGANIQUES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
097189898
WO application number:
US2009036787
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2265261
WO publication number:
WO2009114606
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
11/03/2009
Grant date:
06/07/2016
EP publication date:
29/12/2010
WO publication date:
17/09/2009
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
06/07/2016
EP B1 publication date:
06/07/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
11/03/2029

Applicant

Name:
Adare Pharmaceuticals, Inc.
Legal Form:
From:
06/07/2016
Address:
1200 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, United States (US)
To:

Inventor

1

Name:
VENKATESH, Gopi
Legal Form:
Address:
Vandalia OH 45377, United States (US)

2

Name:
LAI, Jin-Wang
Legal Form:
Address:
Springboro OH 45066, United States (US)

3

Name:
VYAS, Nehal, H.
Legal Form:
Address:
Huber Heights OH 45424, United States (US)

4

Name:
PUROHIT, Vivek
Legal Form:
Address:
East Lyme CT 06333, United States (US)

Priority

1

Priority patent number:
35840
Priority date:
12/03/2008
Priority country:
United States (US)

2

Priority patent number:
209285
Priority date:
12/09/2008
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/30; A61K 9/16; A61K 9/20; A61K 9/48; A61K 9/50;

Publication

European Patent Bulletin

Issue number:
201627
Publication date:
06/07/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2017
Annual fee number:
9
Annual fee amount:
165 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type